Royalty Pharma
RPRX
#999
Rank
NZ$34.61 B
Marketcap
$60.05
Share price
0.81%
Change (1 day)
19.39%
Change (1 year)

Royalty Pharma (RPRX) - P/B ratio

P/B ratio as of March 2025 : 1.87

According to Royalty Pharma's latest financial reports the company has a price-to-book ratio of 8.54528.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Royalty Pharma - P/B ratio (from 2020 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-311.45-12.88%
2023-12-311.67-8.74%
2022-12-311.839.58%
2021-12-311.67-14.92%
2020-12-311.96
2019-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.94 57.35%๐Ÿ‡บ๐Ÿ‡ธ USA
5.89 214.88%๐Ÿ‡บ๐Ÿ‡ธ USA
56.9 2,941.50%๐Ÿ‡บ๐Ÿ‡ธ USA